Drug
Xembify
Xembify: highest development phase Phase 3, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Xembify NCT05645107 | Phase 3 | Hypogammaglobulinemia |
Latest
No recent events.
Follow Xembify on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.